Azacitidine | List of Frontiers open access articles

Original Research

Published on 19 Mar 2025

The real-world analysis of adverse events with azacitidine: a pharmacovigilance study based on the FAERS and WHO-VigiAccess databases

in Pharmacology of Anti-Cancer Drugs

Zhaorui Wang
Linlin Guo
Youfu He
Baiquan Zhang
Yang Wang
Juan Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1555838

5,888 views
1 citation

Review

Published on 05 Jul 2024

Targeting the CD47/SIRPα pathway in malignancies: recent progress, difficulties and future perspectives

in Hematologic Malignancies

Chenyang Jiang
Hao Sun
Zhongxing Jiang
Wenzhi Tian
Shundong Cang
Jifeng Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1378647

10,556 views
33 citations

Original Research

Published on 13 Jun 2024

No advantage of antimicrobial prophylaxis in AML/MDS/CMML patients treated with azacitidine—a prospective multicenter study by the Polish Adult Leukemia Group

in Hematologic Malignancies

Krzysztof Mądry
Karol Lis
Elzbieta Sienkiewicz
Joanna Drozd-Sokołowska
Przemysław Biecek
Oktawia Sośnia
Aleksandra Gołos
Magdalena Olszewska-Szopa
Agata Obara
Zuzanna Walkowiak

Frontiers in Oncology

doi 10.3389/fonc.2024.1404322

3,595 views
2 citations

Original Research

Published on 13 Nov 2018

Cutaneous Leukemic Infiltrates Successfully Treated With Biomodulatory Therapy in a Rare Case of Therapy-Related High Risk MDS/AML

in Experimental Pharmacology and Drug Discovery

Daniel Heudobler
Sebastian Klobuch
Simone Thomas
Joachim Hahn
Wolfgang Herr
Albrecht Reichle

Frontiers in Pharmacology

doi 10.3389/fphar.2018.01279

6,885 views
19 citations

Original Research

Published on 14 Jan 2025

DNA methylation inhibitors adverse reaction characteristic analysis: an analysis based on the European spontaneous adverse event reporting system

in Pharmacology of Anti-Cancer Drugs

Xia Zhang
Yuyu Liu
Qingwang Hou
Yongxin Guo
Youfu He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1527903

1,830 views

Case Report

Published on 01 Apr 2021

Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD

in Cancer Immunity and Immunotherapy

Sun Yao
Chen Jianlin
Qiao Zhuoqing
Li Yuhang
Hu Jiangwei
Hu Guoliang
Ning Hongmei
Zhang Bin
Hu Liangding

Frontiers in Immunology

doi 10.3389/fimmu.2021.639217

6,907 views
13 citations

Case Report

Published on 02 Feb 2022

Case Report: Preemptive Treatment With Low-Dose PD-1 Blockade and Azacitidine for Molecular Relapsed Acute Myeloid Leukemia With RUNX1-RUNX1T1 After Allogeneic Hematopoietic Stem Cell Transplantation

in Alloimmunity and Transplantation

Yutong Tang
Zhenyang Zhou
Han Yan
Yong You

Frontiers in Immunology

doi 10.3389/fimmu.2022.810284

6,656 views
9 citations

Original Research

Published on 08 Jan 2026

Donor lymphocyte infusion combined with azacitidine after allogeneic HSCT in pediatric AML: a single-center retrospective analysis

in Translational Pharmacology

Ana Maria Bica
Andra Daniela Marcu
Cristina Georgiana Jercan
Iuliana Iordan
Andreea Nicoleta Serbanica
Irina Avramescu
Matei Colita
Delia Codruta Popa
Ileana Constantinescu
Alexandra Mihaela Ichim

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1727492

966 views

Original Research

Published on 05 Dec 2025

Azacitidine as maintenance therapy in pediatric de novo acute myeloid leukemia

in Cancer Immunity and Immunotherapy

Chunping Wu
Chunxia Cai
Mei Li
Nainong Li
Yongzhi Zheng
Hao Zheng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1696125

1,441 views

Original Research

Published on 13 May 2025

Prognostic impact of methylation-related gene mutations in elderly acute myeloid leukemia: a real-world retrospective analysis

in Hematology

Yi Chen
Zhengjun Wu
Yanxin Chen
Zhengyang Wang
Ruyu Cai
Yong Wu
Jing Zheng

Frontiers in Medicine

doi 10.3389/fmed.2025.1594784

2,659 views
1 citation

Original Research

Published on 29 Jan 2019

BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes

in Hematologic Malignancies

Fernando Vieira Pericole
Mariana Lazarini
Luciana Bueno de Paiva
Adriana da Silva Santos Duarte
Karla Priscila Vieira Ferro
Fernanda Soares Niemann
Fernanda Marconi Roversi
Sara Teresinha Olalla Saad

Frontiers in Oncology

doi 10.3389/fonc.2019.00016

8,238 views
43 citations

Clinical Trial

Published on 22 Jun 2023

Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia

in Alloimmunity and Transplantation

Yimei Feng
Ting Chen
Yun Zhang
Han Yao
Ping Wang
Lu Wang
Kaniel Cassady
Zhongmin Zou
Yuqing Liu
Lu Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2023.1182251

4,589 views
4 citations

Original Research

Published on 12 Apr 2024

Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience

in Hematologic Malignancies

Francesco Angotzi
Federica Lessi
Matteo Leoncin
Carla Filì
Mauro Endri
Albana Lico
Andrea Visentin
Stefano Pravato
Anna Candoni
Livio Trentin

Frontiers in Oncology

doi 10.3389/fonc.2024.1370405

4,788 views
9 citations

Review

Published on 09 Feb 2024

Azacitidine induced lung injury: report and contemporary discussion on diagnosis and management

in Hematologic Malignancies

Ruah Alyamany
Ahmed Alnughmush
Malak Almutlaq
Mohammed Alyamany
Mansour Alfayez

Frontiers in Oncology

doi 10.3389/fonc.2024.1345492

5,682 views
5 citations

Perspective

Published on 09 Dec 2021

A Combined Histone Deacetylases Targeting Strategy to Overcome Venetoclax Plus Azacitidine Regimen Resistance in Acute Myeloid Leukaemia: Three Case Reports

in Cancer Molecular Targets and Therapeutics

Bin-Ru Wang
Chao-Ling Wan
Song-Bai Liu
Qiao-Cheng Qiu
Tian-Mei Wu
Jun Wang
Yan-Yan Li
Shuai-Shuai Ge
Yan Qiu
Xiang-Dong Shen

Frontiers in Oncology

doi 10.3389/fonc.2021.797941

4,666 views
15 citations

Case Report

Published on 06 Aug 2025

Cholestatic liver injury due to leukemic infiltration in HOX11-positive acute monocytic leukemia: a case report

in Hematologic Malignancies

Huiping Xu
Qunqing She
Linjun Xie

Frontiers in Oncology

doi 10.3389/fonc.2025.1620271

1,932 views

Articles

The real-world analysis of adverse events with azacitidine: a pharmacovigilance study based on the FAERS and WHO-VigiAccess databases

Targeting the CD47/SIRPα pathway in malignancies: recent progress, difficulties and future perspectives

No advantage of antimicrobial prophylaxis in AML/MDS/CMML patients treated with azacitidine—a prospective multicenter study by the Polish Adult Leukemia Group

Cutaneous Leukemic Infiltrates Successfully Treated With Biomodulatory Therapy in a Rare Case of Therapy-Related High Risk MDS/AML

DNA methylation inhibitors adverse reaction characteristic analysis: an analysis based on the European spontaneous adverse event reporting system

Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD

Case Report: Preemptive Treatment With Low-Dose PD-1 Blockade and Azacitidine for Molecular Relapsed Acute Myeloid Leukemia With RUNX1-RUNX1T1 After Allogeneic Hematopoietic Stem Cell Transplantation

Donor lymphocyte infusion combined with azacitidine after allogeneic HSCT in pediatric AML: a single-center retrospective analysis

Azacitidine as maintenance therapy in pediatric de novo acute myeloid leukemia

Prognostic impact of methylation-related gene mutations in elderly acute myeloid leukemia: a real-world retrospective analysis

BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia

Efficacy and safety of venetoclax plus hypomethylating agents in relapsed/refractory acute myeloid leukemia: a multicenter real-life experience

Azacitidine induced lung injury: report and contemporary discussion on diagnosis and management

A Combined Histone Deacetylases Targeting Strategy to Overcome Venetoclax Plus Azacitidine Regimen Resistance in Acute Myeloid Leukaemia: Three Case Reports

Cholestatic liver injury due to leukemic infiltration in HOX11-positive acute monocytic leukemia: a case report